Safety of Sildenafil in Premature Infants
Public ClinicalTrials.gov record NCT03142568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Describe the safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia and determine preliminary effectiveness and pharmacokinetics (PK) of sildenafil. Funding Source - FDA Office of Orphan Products Development (OOPD).
Study identification
- NCT ID
- NCT03142568
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 109 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Days to 28 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2018
- Primary completion
- Feb 28, 2025
- Completion
- Feb 28, 2025
- Last update posted
- Mar 29, 2026
2018 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| University of Florida College of Medicine Jacksonville-Wolfson Children's Hospital | Jacksonville | Florida | 32209 | — |
| University of Florida Jacksonville Shands Medical Center | Jacksonville | Florida | 32209 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Wesley Medical Center | Wichita | Kansas | 67214 | — |
| University of Kentucky | Lexington | Kentucky | 40356 | — |
| Ochsner Baptist Medical Center | New Orleans | Louisiana | 70115 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Children's Hospital of Nevada at UMC | Las Vegas | Nevada | 89106 | — |
| Monmouth Medical Center | Long Branch | New Jersey | 07740 | — |
| Cohen Children's Medical Center of NY | New Hyde Park | New York | 11040 | — |
| Golisano Children's Hospital - University of Rochester Medical Center | Rochester | New York | 14642 | — |
| WakeMed Health and Hospitals | Raleigh | North Carolina | 27610 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03142568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03142568 live on ClinicalTrials.gov.